<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>British Land Company Plc — News on 6ix</title>
<link>https://6ix.com/company/british-land-company-plc</link>
<description>Latest news and press releases for British Land Company Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 13:10:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/british-land-company-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835df6678dffbe2df1258f6.webp</url>
<title>British Land Company Plc</title>
<link>https://6ix.com/company/british-land-company-plc</link>
</image>
<item>
<title>Admission of Shares</title>
<link>https://6ix.com/company/british-land-company-plc/news/admission-of-shares-12</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/admission-of-shares-12</guid>
<pubDate>Tue, 21 Apr 2026 13:10:00 GMT</pubDate>
<description>British Land Company plc announced the admission of 24,500,000 new ordinary shares to trading on the London Stock Exchange, bringing its total issued ordinary shares to 1,035,669,895, with a total of 1,024,403,650 voting rights. This issuance is in connection with the company's recommended cash and share offer for Life Science REIT plc. The new shares are fully fungible with existing ordinary shares and are expected to be credited to CREST accounts or certificates dispatched by May 4, 2026.
</description>
</item>
<item>
<title>Disclosure Table</title>
<link>https://6ix.com/company/british-land-company-plc/news/disclosure-table-40</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/disclosure-table-40</guid>
<pubDate>Mon, 20 Apr 2026 06:45:00 GMT</pubDate>
<description>The Takeover Panel has updated its Disclosure Table, noting the commencement of an offer period for Advanced Medical Solutions Group plc by TA Associates (UK), LLP, with a Rule 2.6 deadline of 17:00 on May 16, 2026, and stating that disclosure of dealings and positions in the offeror is not required. Additionally, the offer period for Life Science REIT plc by The British Land Company plc has been deleted, and the offer period for Gamma Communications plc has been amended. Other companies with on</description>
</item>
<item>
<title>Form 8.3 British Land Co plc</title>
<link>https://6ix.com/company/british-land-company-plc/news/form-83-british-land-co-plc-2</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/form-83-british-land-co-plc-2</guid>
<pubDate>Fri, 17 Apr 2026 14:06:00 GMT</pubDate>
<description>8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation</description>
</item>
<item>
<title>FTSE Russell Index Changes</title>
<link>https://6ix.com/company/british-land-company-plc/news/ftse-russell-index-changes</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/ftse-russell-index-changes</guid>
<pubDate>Mon, 13 Apr 2026 17:00:00 GMT</pubDate>
<description>FTSE Russell has announced changes to the FTSE UK Index Series, effective from the start of trading on April 20, 2026, contingent upon court sanctioning the scheme of arrangement for British Land Co's acquisition of Life Science REIT. Consequently, Life Science REIT will be removed from the FTSE 100, FTSE 350, FTSE All-Share, FTSE All-Share ex Multinationals, FTSE 350 Higher Yield, FTSE UK Dividend +, FTSE SmallCap, and FTSE All-Small indexes. British Land Co will remain a constituent of these i</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/british-land-company-plc/news/holdings-in-company-896</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/holdings-in-company-896</guid>
<pubDate>Fri, 27 Mar 2026 11:25:00 GMT</pubDate>
<description>Bank of America Corporation has increased its notifiable interest in British Land Company PLC, crossing a threshold on March 25, 2026. The total voting rights held now stand at 4.038441%, comprising 0.003940% directly attached to shares and 4.034501% through financial instruments, primarily cash-settled swaps. This represents an increase from their previous notification where they held 3.093961% of voting rights.
Disclaimer*</description>
</item>
<item>
<title>Court and General Meeting Results</title>
<link>https://6ix.com/company/british-land-company-plc/news/court-and-general-meeting-results</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/court-and-general-meeting-results</guid>
<pubDate>Thu, 19 Mar 2026 13:41:00 GMT</pubDate>
<description>Life Science REIT plc announced that shareholders have approved the recommended cash and share offer by The British Land Company PLC at both the Court Meeting and General Meeting held on March 19, 2026. This significant step means the necessary resolutions for the scheme of arrangement have been passed, with a substantial majority of Scheme Shareholders voting in favour of the scheme and Life Science REIT Shareholders approving the resolution to implement the scheme. The acquisition is now progr</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/british-land-company-plc/news/directorpdmr-shareholding-670</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/directorpdmr-shareholding-670</guid>
<pubDate>Wed, 18 Mar 2026 09:23:00 GMT</pubDate>
<description>On March 16, 2026, several executive directors and persons discharging managerial responsibilities at British Land Company PLC purchased ordinary shares and were awarded matching shares under the Company's Share Incentive Plan. Specifically, six individuals each bought 41 ordinary shares at 366.8 pence per share, totaling 246 shares purchased. Additionally, the same six individuals each received 41 matching shares at no cost, resulting in a total of 246 matching shares awarded. These transaction</description>
</item>
<item>
<title>Rule 2.9 Announcement</title>
<link>https://6ix.com/company/british-land-company-plc/news/rule-29-announcement-30</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/rule-29-announcement-30</guid>
<pubDate>Thu, 05 Mar 2026 12:10:00 GMT</pubDate>
<description>British Land Company PLC has issued a Rule 2.9 announcement confirming that on March 5, 2026, 1,785 ordinary shares were allotted under its SAYE Share Option Scheme. As of this announcement, British Land has 999,895,368 ordinary shares in issue, with 11,266,245 held in treasury, resulting in a total of 1,011,161,613 voting rights. This figure is crucial for shareholders to determine their notification obligations under the FCA's Disclosure Guidance and Transparency Rules. The company also noted </description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/british-land-company-plc/news/total-voting-rights-180</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/total-voting-rights-180</guid>
<pubDate>Fri, 27 Feb 2026 14:12:00 GMT</pubDate>
<description>The British Land Company PLC has announced its total issued share capital as of 27 February 2026, which comprises 1,011,159,828 ordinary shares of 25 pence each. Of these, 11,266,245 shares are held in Treasury, leaving a total of 999,893,583 shares with voting rights. This figure is important for shareholders to calculate their notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Form 8.3 - British Land Co plc</title>
<link>https://6ix.com/company/british-land-company-plc/news/form-83-british-land-co-plc-1</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/form-83-british-land-co-plc-1</guid>
<pubDate>Wed, 25 Feb 2026 14:53:00 GMT</pubDate>
<description>8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation</description>
</item>
<item>
<title>Dimensional Fund Advisors Ltd. : Form 8.3 - BRITISH LAND CO PLC - Ordinary Shares</title>
<link>https://6ix.com/company/british-land-company-plc/news/dimensional-fund-advisors-ltd-form-83-british-land-co-plc-ordinary-shares</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/dimensional-fund-advisors-ltd-form-83-british-land-co-plc-ordinary-shares</guid>
<pubDate>Tue, 24 Feb 2026 11:01:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b)Owner or controller of interests</description>
</item>
<item>
<title>Publication of Scheme Document</title>
<link>https://6ix.com/company/british-land-company-plc/news/publication-of-scheme-document-15</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/publication-of-scheme-document-15</guid>
<pubDate>Fri, 20 Feb 2026 07:00:00 GMT</pubDate>
<description>Life Science REIT plc has published a Scheme Document detailing the recommended cash and share offer from The British Land Company PLC, to be implemented via a Scheme of Arrangement. The Life Science REIT Directors unanimously recommend shareholders vote in favour of the acquisition, considering its terms fair and reasonable, with Panmure Liberum providing independent financial advice. The document outlines the full terms, an explanatory statement, meeting notices for a Court Meeting on March 19</description>
</item>
<item>
<title>HSBC HOLDINGS PLC ANNOUNCES RESULTS OF ITS TENDER OFFERS FOR FOUR SERIES OF NOTES</title>
<link>https://6ix.com/company/british-land-company-plc/news/hsbc-holdings-plc-announces-results-of-its-tender-offers-for-four-series-of-notes-16</link>
<guid isPermaLink="true">https://6ix.com/company/british-land-company-plc/news/hsbc-holdings-plc-announces-results-of-its-tender-offers-for-four-series-of-notes-16</guid>
<pubDate>Tue, 09 Sep 2025 10:52:00 GMT</pubDate>
<description>HSBC Holdings plc (the 'Company', 'we' or 'us') today announces the results of its previously announced four separate offers to purchase for cash any and all of the outstanding series of notes listed in the table below. We refer to the outstanding notes listed in the table below collectively as the 'Notes' and separately as a 'series' of Notes. We refer to each offer to purchase a series of Notes as an 'Offer', and collectively as the 'Offers'.</description>
</item>
</channel>
</rss>